ROIV · Roivant Sciences Ltd. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-12 | Sukhatme Mayukh |
Director, President & CIO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.96 to $40.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
44,723 |
| 2026-11-12 | Torti Frank |
President and Vant Chair |
Tax↓
Filing footnotes — Common Shares (Direct)
The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. Represents the "net settlement" by the Issuer of PSUs pursuant to the Issuer's nondiscretionary policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the Performance Condition and the Service Condition applicable to such PSUs. |
Common Shares
|
12,800 |
| 2026-11-12 | Gline Matthew |
Director, CEO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.96 to $40.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
41,179 |
| 2026-11-12 | Torti Frank |
President and Vant Chair |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 30, 2025 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.96 to $41.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
62,493 |
| 2026-11-12 | Gline Matthew |
Director, CEO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.96 to $41.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
7,809 |
| 2026-11-12 | Sukhatme Mayukh |
Director, President & CIO |
Tax↓
Filing footnotes — Common Shares (Direct)
The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. Represents the "net settlement" by the Issuer of PSUs pursuant to the Issuer's nondiscretionary policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the Performance Condition and the Service Condition applicable to such PSUs. |
Common Shares
|
1,737 |
| 2026-11-12 | Sukhatme Mayukh |
Director, President & CIO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.96 to $41.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
8,482 |
| 2026-11-12 | Torti Frank |
President and Vant Chair |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 30, 2025 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.96 to $40.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
329,550 |
| 2026-11-12 | Gline Matthew |
Director, CEO |
Tax↓
Filing footnotes — Common Shares (Direct)
Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. Represents the "net settlement" by the Issuer of PSUs pursuant to the Issuer's nondiscretionary policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the Performance Condition and the Service Condition applicable to such PSUs. |
Common Shares
|
1,600 |
| 2026-11-11 | Pulik Richard |
CFO |
Convert↑
|
Common Shares
|
127,365 |
| 2026-11-11 | Gline Matthew |
Director, CEO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
18,905 |
| 2026-11-11 | Pulik Richard |
CFO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.88 to $41.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
45,195 |
| 2026-11-11 | Torti Frank |
President and Vant Chair |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 30, 2025 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.87 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
240,755 |
| 2026-11-11 | Sukhatme Mayukh |
Director, President & CIO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.87 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
32,672 |
| 2026-11-11 | Pulik Richard |
CFO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
127,365 |
| 2026-11-11 | Pulik Richard |
CFO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
47,635 |
| 2026-11-11 | Torti Frank |
President and Vant Chair |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 30, 2025 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
151,293 |
| 2026-11-11 | Gline Matthew |
Director, CEO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.87 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
30,083 |
| 2026-11-11 | Sukhatme Mayukh |
Director, President & CIO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
20,533 |
| 2026-11-11 | Pulik Richard |
CFO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.94 to $42.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
82,170 |
| 2026-11-10 | Gline Matthew |
Director, CEO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
25,841 |
| 2026-11-10 | Pulik Richard |
CFO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.16 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
125,000 |
| 2026-11-10 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 to $40.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026. |
Common Shares
|
158,194 |
| 2026-11-10 | Torti Frank |
President and Vant Chair |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 30, 2025 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
173,683 |
| 2026-11-10 | Torti Frank |
President and Vant Chair |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 30, 2025 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
218,369 |
| 2026-11-10 | Pulik Richard |
CFO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
125,000 |
| 2026-11-10 | Pulik Richard |
CFO |
Convert↑
|
Common Shares
|
125,000 |
| 2026-11-10 | Gline Matthew |
Director, CEO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. Except as noted below, the remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. As previously reported, the Issuer and the reporting person entered into a letter agreement (the "Gline Letter Agreement") waiving the two-year holding period referenced in the preceding sentence solely in connection with and concurrent with the reporting person donating such Common Shares to a donor-advised fund on or before December 31, 2026. The reporting person has agreed that, upon any such donation, an equivalent two-year holding period will apply to a number of Common Shares underlying the award of stock options granted to the reporting person on April 20, 2022. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
32,490 |
| 2026-11-10 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.93 to $41.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026. |
Common Shares
|
29,749 |
| 2026-11-10 | Sukhatme Mayukh |
Director, President & CIO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.89 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
32,882 |
| 2026-11-10 | Sukhatme Mayukh |
Director, President & CIO |
Other↓
Filing footnotes — Common Shares (Direct)
Represents the sale of Common Shares pursuant to the Issuer's nondiscretionary "sell-to-cover" policy in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of the performance restricted stock units ("PSUs") granted to the reporting person on July 26, 2024 following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The remaining Common Shares issued on settlement of such PSUs (after satisfaction of tax withholding obligations) are subject to a two-year post-vesting holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
26,152 |
| 2026-11-03 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.75 to $36.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026. |
Common Shares
|
200,000 |
| 2026-10-28 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.18 to $36.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026. |
Common Shares
|
200,000 |
| 2026-10-23 | Epperly Melissa B, |
Director |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. |
Common Shares
|
116 |
| 2026-10-23 | MOMTAZEE JAMES C |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |
Common Shares
|
383 |
| 2026-10-23 | Oren Ilan |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |
Common Shares
|
810 |
| 2026-10-23 | Epperly Melissa B, |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |
Common Shares
|
513 |
| 2026-10-23 | MOMTAZEE JAMES C |
Director |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. |
Common Shares
|
77 |
| 2026-10-20 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.38 to $35.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026. |
Common Shares
|
185,856 |
| 2026-10-20 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.39 to $35.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026. |
Common Shares
|
14,144 |
| 2026-10-16 | Gline Matthew |
Director, CEO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of performance restricted stock units ("PSUs"), previously granted to the reporting person on July 26, 2024, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The Common Shares issued on settlement of the PSUs (excluding those withheld for tax withholding obligations, as described above) remain subject to a two-year holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. |
Common Shares
|
34,638 |
| 2026-10-16 | Sukhatme Mayukh |
Director, President & CIO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of performance restricted stock units ("PSUs"), previously granted to the reporting person on July 26, 2024, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of a portion of such PSUs following the achievement of both the performance-based vesting conditions (the "Performance Condition") and service-based vesting conditions (the "Service Condition") applicable to such PSUs. Additional PSUs that have satisfied both the Performance Condition and the Service Condition will be settled in one or more future instalments in accordance with their terms. The Common Shares issued on settlement of the PSUs (excluding those withheld for tax withholding obligations, as described above) remain subject to a two-year holding period before such Common Shares may be sold, measured from the date the Service Condition of the PSUs is satisfied. |
Common Shares
|
19,976 |
| 2026-10-01 | Epperly Melissa B, |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
17,750 |
| 2026-10-01 | Epperly Melissa B, |
Director |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.48 to $36.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026. |
Common Shares
|
900 |
| 2026-10-01 | Epperly Melissa B, |
Director |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.46 to $36.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026. |
Common Shares
|
16,850 |
| 2026-10-01 | Epperly Melissa B, |
Director |
Convert↑
|
Common Shares
|
17,750 |
| 2026-09-30 | Gline Matthew |
Director, CEO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
76,171 |
| 2026-09-30 | Venker Eric |
President & Immunovant CEO |
Convert↑
|
Common Shares
|
200,000 |
| 2026-09-30 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.49 to $36.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. |
Common Shares
|
200,000 |
| 2026-09-30 | Venker Eric |
President & Immunovant CEO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
200,000 |